TABLE 1.
KPC-3-producing strain | Recipient strain | Genotype/construction | Expression |
Meropenem MIC (μg/ml) for KPC-3-producing strain with: |
Meropenem MIC (μg/ml) for recipient | PVmax (μg/ml) |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
OmpK35 | OmpK36 | AcrAB | No drug | QPX | VAB | QPX | VAB | ||||
KPM1271 | KPM1026a | Wild type | FL | FL | BL | 16 | 0.016 | 0.06 | 0.06 | 0.125 | 0.25 |
KPM2601 | KPM2600 | ΔompK35 | NF | FL | BL | 32 | 0.016 | 0.06 | 0.06 | 0.125 | 1 |
KPM2599 | KPM2592 | ΔompK36 | FL | NF | BL | 32 | 0.03 | 0.25 | 0.06 | 1 | 16 |
KPM2067 | KPM2040 | ompK36_fs | FL | NF | BL | 64 | 0.03 | 0.5 | 0.125 | 2 | 16 |
KPM2631 | KPM2613 | ompK36_fs ΔompK35 | NF | NF | BL | 256 | 0.25 | 4 | 0.25 | 2 | 64 |
KPM2965 | KPM2966 | ramR* ompK36_fs ΔompK35 | NF | NF | Up | 256 | 0.5 | 8 | 0.5 | 4 | 64 |
KPM1272 | KPM1027 | ramR_fs | Down | FL | Up | 16 | 0.016 | 0.06 | 0.06 | 0.25 | 2 |
KPM2818 | KPM2658 | ramR_fs ΔompK36 | Down | NF | Up | 256 | 0.5 | 8 | 0.5 | 4 | 64 |
KPM1007 | ΔacrB | FL | FL | NF | ND | ND | ND | 0.06 | ND | ND | |
KP1004 | KPM1206 | ompK35_fs | NF | FL | BL | 32 | 0.016 | 0.03 | 0.03 | 0.25 | 2 |
KP1074 | KPM1211 | ompK35_fs ompK36_GD | NF | GD | BL | 128 | 0.06 | 1 | 0.125 | 2 | 32 |
All strains produced KPC-3 and TEM-1, the genes for which were carried by plasmid pKpQIL. Both the KPM1026a derivatives and clinical isolates also produced a chromosomal SHV enzyme, encoded by blaSHV-24 and blaSHV-11, respectively. ompK35_fs and ompK36_fs, truncated porins due to the frameshift mutation; ramR*, truncated ramR due to the stop codon; FL, full length; NF, nonfunctional; BL, basal level; Up, overexpressed; Down, downregulated; QPX, QPX7728; VAB, vaborbactam at 4 μg/ml; ND, not determined; GD, duplication of two amino acids, Gly134 and Asp135, located within the L3 internal loop and associated with the reduced susceptibility to carbapenems due to constriction of the channel; PVmax, maximal potentiating value, which is the concentration of the BLI that reduces the meropenem MIC to the level seen in the parent strain that lacks KPC, which corresponds to the complete inhibition of KPC. KPC-3-producing strain was not constructed for KPM1007.